Wednesday, July 30, 2014

$1,000 Sovaldi now hepatitis treatment of choice

This undated handout photo provided by Gilead Sciences shows the Hepatitis-C medication Sovaldi. A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans. In less than six months, prescriptions for Sovaldi have eclipsed all other hepatitis-C pills combined, according to new data from IMS Health. (AP Photo/Gilead Sciences) WASHINGTON (AP) — The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.








via Health News Headlines - Yahoo News http://ift.tt/1lS9WUy
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)